Dilatation of cerebral parenchymal vessels mediated by angiotensin type 1 receptor in cats

Neurosci Lett. 2002 Jan 25;318(2):108-12. doi: 10.1016/s0304-3940(01)02493-4.

Abstract

We report the effects of angiotensin II (ANG-II), as well as angiotensin II type 1 (AT1) and type 2 receptor antagonists (CV-11974 and PD-123319, respectively) on the cerebral parenchymal microvessels in cats using the photoelectric method. ANG-II continuously and dose-dependently increased the cerebral blood volume (CBV) for 15 min. Maximum CBV increases were +0.36+or-0.11 vol% for 0.01 nmol/kg (P<0.05), +0.51+or-0.24 vol% for 0.1 nmol/kg (P<0.05), +1.87+or-0.55 vol% for 1 nmol/kg (P<0.05), and +2.14+or-0.77 vol% for 10 nmol/kg (P<0.05). Systemic arterial blood pressure increased at only 1 min following ANG-II infusion (1 and 10 nmol/kg). CV-11974 and PD-123319 per se did not change the resting CBV. CV-11974 completely inhibited the vasodilatory action of ANG-II, however, PD-123319 did not block it. We conclude that ANG-II directly dilates the parenchymal vessels through the AT1 receptor without increasing systemic blood pressure, and that intrinsic ANG-II may not be associated with maintenance of resting vascular tone.

MeSH terms

  • Angiotensin II / metabolism*
  • Angiotensin II / pharmacology
  • Angiotensin Receptor Antagonists
  • Animals
  • Antihypertensive Agents / pharmacology
  • Benzimidazoles / pharmacology
  • Biphenyl Compounds
  • Blood Pressure / drug effects
  • Cats
  • Cerebral Arteries / drug effects
  • Cerebral Arteries / metabolism*
  • Cerebral Cortex / blood supply*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / metabolism
  • Cerebrovascular Circulation / drug effects
  • Cerebrovascular Circulation / physiology*
  • Dose-Response Relationship, Drug
  • Female
  • Imidazoles / pharmacology
  • Male
  • Microcirculation / drug effects
  • Microcirculation / metabolism*
  • Pyridines / pharmacology
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Receptors, Angiotensin / agonists
  • Receptors, Angiotensin / metabolism*
  • Tetrazoles / pharmacology
  • Vasodilation / drug effects
  • Vasodilation / physiology*

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Imidazoles
  • Pyridines
  • Receptor, Angiotensin, Type 1
  • Receptor, Angiotensin, Type 2
  • Receptors, Angiotensin
  • Tetrazoles
  • Angiotensin II
  • PD 123319
  • candesartan